PACB News and Press, Pacific Biosciences of California Inc. From 08/31/21

Are These The Top Health Care Stocks To Watch This Week? While investors look for up-and-coming stocks in the stock market now, health care stocks continue to shine. After all, this sector of the market is home to countless companies looking to improve our overall quality of...

MENLO PARK, Calif., Aug. 09, 2021 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (NASDAQ: PACB) announced today that its executives will be speaking at the following investor conference: UBS Genomics 2.0 and MedTech Innovations Summit on August 11, 2021, Panel Discussio...

Pacific Biosciences, a San Francisco Bay area company offering long-read sequencing platforms, will acquire Omniome, a San Diego short-read company, for up to $800 million. Shanghai's Zai Lab and Schrödinger of New York formed a global collaboration to develop a novel oncology pr...

Former Penny Stocks Climbing Higher In 2021 When you think about penny stocks, what comes to mind first? Does it have something to do with making money quickly? Maybe it’s more along the line of getting in on the ground floor of a company before it takes off. On the other hand, i...

Image source: The Motley Fool. Pacific Biosciences of California (NASDAQ: PACB) Q2 2021 Earnings Call Aug 03, 2021 , 4:30 p.m. ET Operator Continue reading For further details see: Pacific Biosciences of California (PACB) Q2 2021 Earnings...

Recently launched proprietary HiFi and SMRT sequencing technology leading to 47% growth in revenues for 2021. Long-term growth potential secured with strategic R&D partnerships with Invitae and Asuragen aimed at reducing the cost of genome sequencing. Global commercial expansi...

Healthcare has undergone massive changes in the past decade. A global pandemic will overshadow much of it in the eyes of history, but legislation, reimbursement changes, and scientific breakthroughs permeated the 2010s. It probably leaves investors wondering what the next decade has in stor...

Pacific Biosciences of California, Inc. (PACB) Q2 2021 Earnings Conference Call August 03, 2021, 16:30 ET Company Participants Todd Friedman - Director, IR Christian Henry - President, CEO & Director Susan Kim - CFO Mark Van Oene - COO Conference Call Participants Tycho Peterson - JPMorga...

Pacific Biosciences of California (NASDAQ:PACB) is trading marginally lower despite a revenue beat with its Q2 2021 financials.  GAAP EPS was in line with the consensus estimates. Revenue for the quarter has risen ~79% YoY to $30.6M, driven by $14.3M and $12.2M in instrument an...

MENLO PARK, Calif., Aug. 03, 2021 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (NASDAQ: PACB) today announced financial results for the quarter ended June 30, 2021. Record second quarter revenue reflects continued quarter-over-quarter growth Revenue for the seco...